IDR knowledge base for primary immunodeficiencies by Samarghitean, Crina et al.
This document has been downloaded from
Tampub – The Institutional Repository of University of Tampere
Publisher's version
Authors: Samarghitean Crina, Väliaho Jouni, Vihinen Mauno
Name of article: IDR knowledge base for primary immunodeficiencies
Year of publication: 2007
Name of journal: Immunome Research
Volume: 3
Number of issue: 6
Pages: 1-6
ISSN: 1745-7580
Discipline: Medical and Health sciences / Medical biotechnology
Language: em
School/Other Unit: Institute of Biomedical Technology
URL: http://www.immunome-research.com/content/3/1/6
URN: http://urn.fi/urn:nbn:uta-3-607
DOI: http://dx.doi.org/10.1186/1745-7580-3-6
All material supplied via TamPub is protected by copyright and other intellectual property rights, and
duplication or sale of all part of any of the repository collections is not permitted, except that material
may be duplicated by you for your research use or educational purposes in electronic or print form.
You must obtain permission for any other use. Electronic or print copies may not be offered, whether
for sale or otherwise to anyone who is not an authorized user.
BioMed CentralImmunome Research
ssOpen AcceDatabase
IDR knowledge base for primary immunodeficiencies
Crina Samarghitean1, Jouni Väliaho1 and Mauno Vihinen*1,2
Address: 1Institute of Medical Technology, FI-33014 University of Tampere, Finland and 2Research Unit, Tampere University Hospital, FI-33520 
Tampere, Finland
Email: Crina Samarghitean - crina.samarghitean@uta.fi; Jouni Väliaho - jouni.valiaho@uta.fi; Mauno Vihinen* - mauno.vihinen@uta.fi
* Corresponding author    
Abstract
Background: The ImmunoDeficiency Resource (IDR) is a knowledge base for the integration of
the clinical, biochemical, genetic, genomic, proteomic, structural, and computational data of
primary immunodeficiencies. The need for the IDR arises from the lack of structured and
systematic information about primary immunodeficiencies on the Internet, and from the lack of a
common platform which enables doctors, researchers, students, nurses and patients to find out
validated information about these diseases.
Description: The IDR knowledge base, first released in 1999, has grown substantially. It contains
information for 158 diseases, both from a clinical as well as molecular point of view. The database
and the user interface have been reformatted. This new IDR release has a richer and more
complete breadth, depth and scope. The service provides the most complete and up-to-date
dataset. The IDR has been integrated with several internal and external databases and services. The
contents of the IDR are validated and selected for different types of users (doctors, nurses,
researchers and students, as well as patients and their families). The search engine has been
improved and allows either a detailed or a broad search from a simple user interface.
Conclusion: The IDR is the first knowledge base specifically designed to capture in a systematic
and validated way both clinical and molecular information for primary immunodeficiencies. The
service is freely available at http://bioinf.uta.fi/idr and is regularly updated. The IDR facilitates
primary immunodeficiencies informatics and helps to parameterise in silico modelling of these
diseases. The IDR is useful also as an advanced education tool for medical students, and physicians.
Background
Primary immunodeficiency disorders (PIDs) impair the
function of the immune system. Patients with these intrin-
sic defects have increased susceptibility to recurrent and
persistent infections, and they may also have autoim-
mune and cancer related symptoms. Most PIDs are rare
and the diagnosed patients for a condition are often ran-
domly spread out around the world. More than 150 PIDs
affecting the immune system have been described and
more than 100 genes involved in PIDs have been identi-
fied [1]. The number of mutations, identified in unrelated
families with different PIDs, totals over 4,500 [2].
There is plenty of information related to immunology and
immunodeficiencies on the Internet. General immunome
information can be found e.g. from IMGT [3], AntiJen [4]
and Immunome [5] databases and more specific data e.g.
in ImmTree [6], IDbases [2], SYFPEITHI [7], and Immune
Published: 29 March 2007
Immunome Research 2007, 3:6 doi:10.1186/1745-7580-3-6
Received: 9 February 2007
Accepted: 29 March 2007
This article is available from: http://www.immunome-research.com/content/3/1/6
© 2007 Samarghitean et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 6
(page number not for citation purposes)
Immunome Research 2007, 3:6 http://www.immunome-research.com/content/3/1/6Epitope Databases and Analyse Resources (IEDB) [8]. The
scattering of the disease-related information in the litera-
ture and the Internet is a big obstacle for those interested
in rare diseases. Users often have problems in finding rel-
evant information and assessing the quality of informa-
tion from the Internet. Biomedical information holds
promises for developing informatics methods for postge-
nomic and personalised medicine. The new knowledge
can be applied in the prevention, diagnosis and treatment
of diseases. Computerised information sources have
many challenges related, for example, to terminology and
ontology building, information extraction from texts,
knowledge discovery from collections of documents,
sharing and integrating knowledge from factual and tex-
tual databases, and semantic annotation. There is a need
for a standardised nomenclature and data form that can
be easily handled by computers and presented on any
platform.
The ImmunoDeficiency Resource (IDR) integrates bio-
medical information related to PIDs into a web accessible
knowledge base. The fact files, which form the core of the
system, integrate biomedical knowledge from several het-
erogeneous and autonomous sources.
This paper illustrates numerous new features and
improvements, which have been implemented since pre-
vious IDR releases [9,10], and details about data collec-
tion and automated database integration. The IDR is
developed to serve anybody interested in PIDs and to pro-
vide relevant, up-to-date and validated information in an
easily understandable and usable format.
Construction and Content
The IDR has been designed and implemented using
eXtensible Markup Language XML [11], a system compris-
ing a native XML database and an XML server. Data within
the IDR is structured into document-centred XML and
SHTML files. The interface to the IDR has been completely
redesigned. It consists of a dynamic layout that can adapt
to different screen sizes, from wide desktop screens to
small mobile devices.
Numerous new features, such as the classification of PIDs,
genes related to immunodeficiency, reference sequences,
protein structures and animal model pages, have been
added. Links are also provided to other IDR-fact file data-
bases [12], IDbases for PID-causing mutations [2], and
IDdiagnostics for PID diagnostic laboratories [13].
The IDR aims to provide comprehensive integrated
knowledge about immunodeficiencies in an easily acces-
sible form, targeting different types of users (doctors, sci-
entists, nurses and patients and their families). The
resource includes clinical, biochemical, genetic, structural
and computational data and analyses. The main headings
of the IDR are General Information, Bioinformatics,
Immunology, and Interest Groups (Fig. 1).
The General Information class
Immunodeficiencies in the IDR are classified according to
the molecular defects criteria [1] with links to the Online
Mendelian Inheritance in Man (OMIM) database [14].
Information about the affected genes and loci are pro-
vided and linked with corresponding services. The ESID
and PAGID recommendations for diagnostic criteria [15],
the American Academy of Allergy, Asthma and Immunol-
ogy (AAAAI) parameters [16], and different diagnostic
guidelines [17] are also included. There is also a list for
PID abbreviations.
At the core of the system are fact files (Fig. 2), which store
information regarding disorders, genes, mutations, pro-
tein sequences, online resources, organisations and asso-
ciations [12]. At present there are fact files for 158
diseases. The user interface allows fast access to the infor-
mation. International Classification of Diseases (ICD)
codes [18] are provided for those diseases where the codes
are available. Each fact file provides basic information
about the disease and the affected gene. The fact files have
hyperlinks to other reliable Internet resources. The fact file
data model and the Inherited Disease Markup Language
(IDML) [12] were developed to facilitate disease informa-
tion integration, storage and exchange. The fact files make
use of the following specifications, standards and data-
bases: HUGO nomenclature [19], Swiss-Prot [20], Gene-
Card [21], and SOURCE [22].
The IDML fact files have been generated for each PID. The
major concepts in the fact files are general information,
clinical information, molecular biology and other
resources – all of which are linked to related information
services (Fig. 1). Each of these elements comprises one or
more additional levels. Table 1 summarised the major
concepts and descriptions of the elements in the IDR-fact
files.
The IDML schema [23], IDML document type definition
file [24], examples of an IDML-document, and documen-
tation on the syntax can be read from [25]. The validation
in IDML fact files is done with the IDML validator pro-
gram, available online at [26].
The Bioinformatics class
The bioinformatics section integrates numerous Web
based services (Ensemble [27], Source [22], EntrezGene
[28], euGenes [29], GeneLynx [30], UniGene [31], Gene-
Card [21], GenAtlas [32]). Reference sequences for PID
genes are available for DNA and RNA from the EMBL
database, and for protein data from SwissProt [20]. WhenPage 2 of 6
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ualisation tools in the PDB [33]. The animal models page
has been updated.
The IDbases [2] section provides, in addition to our own
mutation registries, links to other IDbases. At the moment
we have 115 databases with over 4,500 patient entries.
The Immunology and Interest Group classes
The immunology section lists collections of immunology
related data sources including lectures on immunology
and immunodeficiencies, and links to over 40 online
immunology journals. A new feature is the glossary,
which provides explanations for more than 800 immu-
nology terms. Glossary terms are cross linked by each
other, so by clicking one of these terms, such as 'antigen',
not only is the explanation for the term provided, but also
for a group of terms related to 'antigen'. This gives a broad
overview of immunology terminology, which also makes
it a useful tool for education.
The interest group section contains links to immunology,
immunodeficiency, and nursing and patient organisa-
tions. Several societies are related to immunodeficiency
research, care and patients. The list of meetings and work-
shops is continuously updated.
Utility and Discussion
Accuracy and validation of data
The Internet contains a large number of pages. Search
engines often give thousands of links but usually the most
difficult task is to differentiate the useful and reliable data
from other search results. In the IDR, the experts check all
the data and approve only those sites with solid scientific
and medical information. There will be at least one exter-
nal expert for each immunodeficiency. Nursing and
patient societies are also involved in the data validation
process for their own interest groups.
The IDR is easy to navigate. The pages are colour coded for
different interest groups: researchers, physicians, nurses,
patients and families. By selecting the group of interest,
the user can get specific pages produced and tailored for
the particular group. This makes it easier for the user to
find the most relevant and useful information. The IDR
also provides an advanced text search facility, which can
utilise Boolean logic searches with multiple keywords.
Within a typical search, the user-entered search criteria are
Concept map for the IDR knowledge serviceFigure 1
Concept map for the IDR knowledge service. IDR is composed of web pages grouped in to different class categories and 
a fact file database. The system is integrated with different internal and external databases to serve a wide category of users.Page 3 of 6
(page number not for citation purposes)
Immunome Research 2007, 3:6 http://www.immunome-research.com/content/3/1/6carried from an SHTML or XML form to a category specific
PERL script, which performs the database queries.
The IDR can be used to discover many kinds of informa-
tion as it is integrated with internal (IDbases and IDdiag-
nostics) and external databases (Fig. 1).
The IDbases have recently been integrated with the ESID
patient registry [34], which collects clinical data for
patients. This collaboration facilitates direct submission
both to the ESID registry and IDbases. A similar arrange-
ment will be made with the US Immunodeficiency Net-
work (USIDNET).
A fact file is a user oriented user interface, which serves as
a good starting point to explore information on hereditary
diseases. The user can find not only information about the
disease nomenclature and classification (OMIM, ICD10),
but also a clinical description of the disease, inheritance
and prevalence. The IDR-fact file facilitates finding infor-
mation about laboratories which perform genetic tests for
PIDs, using direct links to IDdiagnostics [13], GeneTest
IDR user interfaceFigure 2
IDR user interface. Screenshots of the main IDR pages. The new user interface provides faster access to the information and 
different new features, such as classification of diseases (top left), the gene related with the PIDs and their reference sequences 
(top right), glossary terms for immunology (bottom right), and diagnostic tools (bottom left). At the core of the system are fact 
files that provide clinical and molecular information for 158 primary immunodeficiency diseases (centre).Page 4 of 6
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genes contains the nomenclature, including aliases,
sequences, chromosomal location and maps, variations,
and mutations. The IDR-fact files also contain informa-
tion about protein functions, structure, domains, motifs,
subcellular location and post-translational modifications.
PID researchers will also find in the IDR-fact files lots of
information for each disease to keep up-to-date with the
literature, meetings and different associations in the field.
Future work
In the near future a new tool for faster and more accurate
diagnosis, PIDexpert, will be added. PIDexpert is a medi-
cal expert system, designed to give the diagnostic picture
of PIDs based on symptoms, signs, medical history, phys-
ical findings, and laboratory tests. Future tasks in the
development of the IDR will focus on expanding its
depth, breadth, and scope. The external database updates
will be monitored so that any alterations are mirrored
within the archive. We plan to further develop the IDR
based on user feedback and our interactions with the PID
community.
Conclusion
The IDR contains systematically organised, continuously
updated and validated information that is valuable for cli-
nicians and researchers and can improve the medical care
of PIDs. IDR is the first knowledge service designed to cap-
ture both clinical and molecular information about pri-
mary immunodeficiencies and to address different types
of users. It is validated and will be updated frequently. The
IDR facilitates PID informatics and helps to parameterise
in silico modelling of these diseases. The IDR has many
potential users throughout the PID community, from doc-
tors to patients and from immunoinformaticians to exper-
imental immunologists and structural biologists.
Availability and requirements
The IDR database is freely available for academic use from
the URL: http://bioinf.uta.fi/idr.
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